Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
AbbVie.
Real, source-linked trial activity for AbbVie: 9 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE3 3PHASE2 3PHASE4 1N/A 1PHASE1 1
Newest AbbVie trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared t | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 20d ago | Study to Assess Adverse Events and How Effective NOA LIFT is Compared | Ph 3 | RECRUITING | ↗ |
| 20d ago | Study to Assess Participant Satisfaction After Jawline and Neck Treatm | Ph 4 | NOT_YET_RECRUITING | ↗ |
| 33d ago | A Study to Assess Adverse Events and Change in Disease Activity With T | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 47d ago | A Study to Assess Adverse Events, Change in Disease Activity and Optim | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 48d ago | Effectiveness of Upadacitinib and Biologics for the Achievement of Min | N/A | NOT_YET_RECRUITING | ↗ |
| 52d ago | A Study to Assess the Safety, Tolerability and How Single Ascending Do | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 54d ago | A Study to Assess the Safety and Efficacy of AGN-151586 Injections for | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 55d ago | A Study to Evaluate Adverse Events and Change in Disease Activity With | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for AbbVie (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.